Agency Information Collection Activities; Announcement of OMB Approval; Current Good Manufacturing Practices for Blood and Blood Components; Notification of Consignees Receiving Blood and Blood Components at Increased Risk for Transmitting HIV Infection

Özet

The Food and Drug Administration (FDA) is announcing that a collection of information entitled "Current Good Manufacturing Practices for Blood and Blood Components; Notification of Consignees Receiving Blood and Blood Components at Increased Risk for Transmitting HIV Infection" has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.